Evommune earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest EVMN earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$21.7M, down 23.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EVMN reported annual earnings of -$68.9M, with 0.8% growth.
EVMN earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
EVMN Return on Equity
Insufficient data to display
EVMN Return on Assets
Insufficient data to display
Be the first to know when EVMN announces earnings.
Evommune (NYSE: EVMN) reported Q1 2026 earnings per share (EPS) of -$0.64, up 93.25% year over year. Total EVMN earnings for the quarter were -$21.67 million. In the same quarter last year, Evommune's earnings per share (EPS) was -$9.48.
As of the last Evommune earnings report, Evommune is currently losing money. Evommune's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.
What was EVMN's earnings growth in the past year?
As of Evommune's earnings date in Q2 2026, Evommune's earnings has grown year over year. EVMN earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.